- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (630)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (902)
- Research (394)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (606)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Q&A: Testicular Cancer Survivorship
BY MD Anderson
3 minute read | Published June 30, 2011
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on June 30, 2011
The survivorship stage in a cancer journey does not always signify the end of a cancer experience.
For testicular cancer survivors, it is important to receive long-term, follow-up care after treatment ends.
Long-term, follow-up care helps survivors:
- Monitor for late effects and recurrence
- Cope with physical changes
- Be informed about sexual and reproductive health
- Address psychosocial concerns
- Learn health behaviors that reduce cancer risk
- Develop a comprehensive follow-up care plan
- Be connected to support services
At MD Anderson, testicular cancer survivors receive long-term, follow-up care through the Genitourinary Cancer Survivorship Clinic. In addition, the clinic helps those treated at MD Anderson for bladder, prostate, kidney and penile cancer.
William Osai, an advanced practice nurse who oversees the Genitourinary Cancer Survivorship Clinic, answers questions concerning testicular cancer survivorship issues.
All of our survivors have either undergone chemotherapy or radiation, had a testicle removed (orchiectomy) or experienced a combination of these three treatments. After undergoing treatment, such as an orchiectomy, patients' concerns aren't usually about personal appearance, but more about sexual function.
Patients worry about being able to experience a "normal" sex life. Also, fertility is a concern commonly discussed. We offer fertility counseling and information on sperm banking.
Since family history is a risk factor for testicular cancer, patients also worry about the increased risk of their children developing testicular cancer.
After treatment ends, many survivors want their lives to return to the way they were before cancer. Do your patients find that a permanent physical change, like the loss of a testicle, is a constant reminder that their lives are different?
Most patients accept the removal of a testicle as part of their treatment fairly easily. They see it as a necessary step towards beating their cancer.
Causing more of a reminder is hypogonadism. After an orchiectomy, hypogonadism can occur when the remaining sex gland (testicle) produces little or no hormones.
Hypogonadism can cause:
- Impotence
- Loss of sex drive
- Infertility
- Osteoporosis
- Fatigue
- Insulin resistance
- High blood cholesterol and triglycerides
- Weight gain
Testosterone replacement therapy typically relieves these effects.
For many men, testicles are symbolic of manhood and the removal of one can lead to embarrassment or fear about a partner's reaction. Do you find that men are open to asking for help after treatment to address this?
From diagnosis, addressing sexual issues plays an integral part in the planning of treatment. My experience is that most patients are open to discussing sexual issues during and after treatment. Because testicular cancer patients are generally young, body image, sexuality and fertility are important subjects for them.
Physical changes after removal of the testicle can be remedied with prosthesis. However, only a handful of the patients in my clinic have prosthesis. This is mirrored in research data, which shows that only a minority of patients request prosthesis after undergoing an orchiectomy.
Research also shows that orchiectomy patients are more concerned about undressing in public rather than before a sexual partner.
If survivors are interested in counseling or support groups to address their concerns, the clinic serves as a good resource for referrals to MD Anderson support services. We can also give them information on support organizations within their communities.